Cookies?
Library Header Image
LSE Research Online LSE Library Services

IMI work package 5: report 1:b:iii benefit - riskwave 1 case study report:Raptiva® (efalizumab)

Micaleff, Alain, Callreus, Tornbjorn, Phillips, Lawrence D., Hughes, Diana, Hockley, Kimberley, Wang, Nan and Luciani, David (2013) IMI work package 5: report 1:b:iii benefit - riskwave 1 case study report:Raptiva® (efalizumab). . PROTECT Consortium, London.

Full text not available from this repository.

Item Type: Monograph (Report)
Official URL: http://www.imi-protect.eu/
Additional Information: © 2013 PROTECT Consortium
Divisions: Management
Subjects: H Social Sciences > HD Industries. Land use. Labor > HD61 Risk Management
R Medicine > RS Pharmacy and materia medica
R Medicine > RZ Other systems of medicine
Sets: Departments > Management
Date Deposited: 08 Dec 2015 17:05
Last Modified: 20 Feb 2019 02:00
Projects: Grant Agreement n° 115004, FP7/2007-2013
Funders: Innovative Medicines Initiative Joint Undertaking, European Union's Seventh Framework Programme, EFPIA
URI: http://eprints.lse.ac.uk/id/eprint/64631

Actions (login required)

View Item View Item